FDA Approves Methoxy Polyethylene Glycol-Epoetin Beta for Anemia Associated With Chronic Kidney Disease in Pediatric Patients on Dialysis
Jun 07
2018
The Food and Drug Administration approved methoxy polyethylene glycol-epoetin beta (Mircera®, Vifor Pharma Inc.) for the treatment of pediatric patients 5 to 17 years of age on hemodialysis who are converting from another ESA after their hemoglobin level was stabilized with an ESA.
